The company has issued more shares over this period, which dilutes each existing shareholder’s stake.
Diluted shares outstanding: 136.1M (2021) → 165.4M (2025)
VentriPoint Diagnostics Ltd. (VPTDF) is a medical technology company dedicated to creating and bringing to market diagnostic tools for the global assessment of patients with cardiac conditions. The company's primary offering is the VentriPoint Medical System (VMS), an advanced medical imaging platform. This system, utilizing its VMS+ software, constructs precise three-dimensional representations of a patient's heart chambers by processing echocardiogram and magnetic resonance imaging (MRI) data. It is designed to yield consistent and accurate volumetric and functional measurements, including ejection fraction. Additionally, VentriPoint is actively developing a suite of specialized applications to address a broad spectrum of heart diseases and diverse imaging techniques. This portfolio includes solutions for conditions such as congenital heart defects, pulmonary hypertension, cardiotoxicity observed in oncology patients, and cardiac complications stemming from COVID-19. Established in 2004, the company's headquarters are located in Toronto, Canada.
When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.
YoY Growth Rate
Revenue data limited
+84.8% YoY
YoY Growth Rate
EPS growth accelerating
C$372,606/ year
↓ Declining (-62% vs prior year)
207.3% of revenue
11.5x the sector average (18%)
R&D spend declining — could signal cost-cutting or efficiency
~0 months
C$55,343 cash & investments
Short runway — potential dilution ahead through share issuance
VentriPoint Diagnostics has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.
The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.
Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Free cash flow is negative. They are burning cash, not generating it.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
